Farshad Guirakhoo - May 3, 2022 Form 4 Insider Report for Vaxxinity, Inc. (VAXX)

Role: Chief Scientific Officer
Signature: Rene Paula Molina, attorney-in-fact for Farshad Guirakhoo
Stock symbol: VAXX
Transactions as of: May 3, 2022
Transactions value $: $5,700
Form type: 4
Date filed: 5/5/2022, 01:39 PM
Previous filing: Aug 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VAXX	Class A common stock	Options Exercise	$5.7K	+10K		$0.57^*	10K	May 3, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VAXX	Stock Option (right to buy)	Options Exercise	$0	-10K	-7.89%	$0.00	117K	May 3, 2022	Class A common stock	10K	$0.57	Direct	F1
holding	VAXX	Stock Option (right to buy)						42K	May 3, 2022	Class A common stock	42K	$13.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These options are subject to a four year time-based vesting schedule, with 25% vested on 6/5/2021 and the remainder vesting in equal installments each month during the remainder of the vesting period.
F2	These options are subject to a four-year time-vesting schedule, with 25% vesting on 11/11/2022 and the remainder vesting in equal installments each month during the remainder of the vesting period.